ADC Therapeutics SA
ADCT
$1.29-1.53%
End of day · as of Sep 24, 2026, 7:15 PM ET
Mkt cap
$141.18M
EV/Sales
-1.44
P/E ratio
N/A
FY2025 Revenue
$81.36M
EPS (TTM)
$-0.58
Gross Margin (FY2025)
92.87%
Profit Margin (FY2025)
-175.31%
Beta
N/A
Div yield
N/A
Sector
Healthcare
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Latest reported ADCT revenue for 2025-12-31 was $81.4M. Net income was -$142.6M. Revenue was up 14.9% from 2024-12-31 to 2025-12-31. ADCT currently screens at market cap $141.2M.
Use this ADCT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ADCT income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
ADC Therapeutics SA (ADCT) is a biotechnology company in the Healthcare sector.
Latest cached ADC Therapeutics SA (ADCT) revenue for Dec 31, 2025 was $81.4M. Net income was -$142.6M. Statements: https://lician.com/financials/adct
ADC Therapeutics SA (ADCT) market capitalization is $141.2M on the latest cached snapshot.
ADC Therapeutics SA (ADCT) cached previous close $1.31; day range $1.24 – $1.31; volume 1,574,681. Session quote: https://lician.com/quote/adct
ADC Therapeutics SA (ADCT) latest cached earnings event is "ADCT earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ADCT filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/adct